Subject: PSID CEO Outlines How Company will Build Upon 2017 Successes in 2018 Projects 30% Revenue Growth

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
PSID CEO Outlines How Company will Build Upon 2017 Successes in 2018 Projects 30% Revenue Growth
Hot Stock to WatchHot Stock to Watch

Company: PositiveID Corporation (Pink Sheets: PSID)


Last:

Price: 0.0027

Change (%): + 0.0004 (17.39)

Volume: 17,305,252
PSID Chart

PositiveID Corporation Discusses 2017 Highlights and 2018 Outlook and Growth Projections in New Interview with SmallCapVoice.com

AUSTIN, Texas, Jan. 11, 2018 (GLOBE NEWSWIRE) - SmallCapVoice.com, Inc. today announced it conducted a new audio interview with PositiveID Corporation (“PositiveID” or the “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics. The interview can be heard at https://smallcapvoice.com/blog/1-9-18-smallcapvoice-interview-with-positiveid-corporation-psid.

In the interview, William J. Caragol, Chairman and CEO of PositiveID, discussed 2017 highlights for the Company’s medical device, mobile labs, and molecular diagnostics product lines, and provided additional insight on the Company’s projected consolidated year-over-year revenue growth of more than 30% for the 2017 fourth quarter and 2018 first quarter.

PositiveID operates in three segments: Mobile Labs, comprised of its E-N-G Mobile Systems, Inc. subsidiary, a specialty vehicle manufacturer; Medical Devices, comprised of its Thermomedics subsidiary, which markets the Caregiver® non-contact thermometer; and Molecular Diagnostics, comprised of its ExcitePCR Corporation subsidiary, consisting of its FireflyDX family of products for real-time pathogen detection at the point-of-need/point-of-care.

Continue Reading

Like Us on FacebookFollow Us on Twitter

IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks